JLE

Epileptic Disorders

MENU

The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre Volume 15, issue 3, September 2013



Figure 1 Efficacy of LEV according to epilepsy syndromes (A) and the relationship between treatment pattern and the efficacy of LEV in generalised epilepsy (B) and localisation-related epilepsy (C). Pearson's χ2 test and *linear by linear association were used for statistical analyses.



Figure 2 Retention curve illustrating the percentage of patients still being treated with LEV, as calculated using a life-table method. (A) Total study group. (B) Comparison between patients with generalised epilepsy and patients with localisation-related epilepsy.